ONTO enters earnings week bruised but not broken

Onto Innovation heads into its November 5 earnings report down 34% over the past month, yet the week that just closed was fractionally positive, a small stabilisation that masks a violent Thursday, when the stock fell 9.2% in a single session to close at $201.57.

The most important thing to understand about that fall is the company it kept. Lam Research dropped 6% on Thursday. Applied Materials fell 7.5%. FormFactor shed more than 10%. KLA Corp lost 5.7%. The move in ONTO was large but squarely within the scatter of the peer group, reinforcing the reading from the previous note: this remains sector pressure, not a company-specific verdict. The one outlier to the upside was Entegris, which gained nearly 15% on the week, suggesting the group is not moving as one bloc, and investors are beginning to make finer distinctions within the equipment and materials space.

The borrow market continues to offer no ammunition to a short thesis. Availability is extraordinarily loose at roughly 7,200%, meaning shares available to borrow dwarf shares already borrowed by a factor of more than 70. Short interest at 5.6% of the free float has crept up about 1.2% on the week and 15% over the past month, but the cost to borrow is just 0.43%, barely above last week's level despite the share price decline. That combination, rising but still modest short interest, ample availability, and negligible borrow costs, means the selling pressure has not come from a coordinated short campaign. Options traders are modestly more cautious than usual: the put/call ratio is running at 0.43, roughly 1.3 standard deviations above its 20-day average of 0.38, but nowhere near the 52-week high of 0.89. Defensive hedging is ticking higher into earnings, not spiking.

The Street remains constructively positioned, though the price collapse has made the gap between current price and consensus targets striking. The mean analyst target is around $387, nearly double Thursday's close, reflecting initiations from Goldman Sachs at $400 and RBC at $400 in August and early October respectively, as well as targets from Jefferies, Oppenheimer and Cantor in the $390 to $450 range. Those targets were set when the stock traded materially higher, and the most recent substantive move was Morgan Stanley trimming its target from $383 to $360 in September while keeping an Overweight rating. The forward earnings yield factor ranks in the 57th percentile, the EV/EBITDA multiple has compressed roughly 0.6 turns over the past month, and the price-to-book has fallen by around 1.8 turns in 30 days. The analyst recommendation differential, which measures how far above the neutral line the consensus sits, ranks in the 92nd percentile, a signal that the Street's conviction has not moved despite the stock's decline. The bear case centres on China revenue concentration near 30%, competition from KLA and ASML in adjacent inspection niches, and the reality that panel-level packaging volume production is not expected until 2028. The bull case rests on the Dragonfly and Atlas platform share gains in advanced packaging and HBM, where process-control intensity is rising and the company has minimal direct China exposure in its fastest-growing product lines.

One signal worth noting in the alt data is a Wikipedia attention reading: retail interest in ONTO is running at a z-score of 2.1 against its own 90-day history as of late October, an elevated but not extreme level. This dataset has not been measured to lead the company's financials, so it is colour rather than signal. What it does reflect is that the stock's sharp move has caught retail attention at an unusual rate, consistent with the kind of volatility that draws a broader audience ahead of a print.

The next number that matters is the November 5 report. After the August earnings, the stock gained 11.7% on the day and 22.4% over the following week, so the market's recent pricing of downside risk sits in some tension with that recent history. The question heading into that release is whether the 34% correction over the past month has already discounted the macro and cyclical risks, or whether the sector-wide pressure reflects something more durable about WFE spending trajectories that the company's own guidance will need to address.